What changed
On November 13, 2026, Xylem's Board of Directors approved a new share repurchase program authorizing up to $1.5 billion of common stock purchases. The program has no expiration date and permits repurchases through open market purchases or otherwise in compliance with applicable laws. The program does not obligate the company to acquire any particular amount of stock and may be suspended at any time at the company's discretion.
Why it matters
On November 13, 2026, Xylem's Board of Directors approved a new share repurchase program authorizing up to $1.5 billion of common stock purchases. The program has no expiration date and permits repurc